01 1Qilu Tianhe Pharmaceutical Co., Ltd.
01 1TADALAFIL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-27
Pay. Date : 2016-09-06
DMF Number : 30860
Submission : 2016-09-05
Status : Active
Type : II
20
Shandong Anxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is TADALAFIL, with a corresponding US DMF Number 30860.
Remarkably, this DMF maintains an Active status since its submission on September 05, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2017, and payment made on September 06, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
